Clinical Takeaway Trauma-focused treatments for PTSD remain effective even among patients who use cannabis, including those with co-occurring substance use disorders. Cannabis use does not appear to undermine the benefits of evidence-based...
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Clinical Takeaway Cannabinoids have been studied across a wide range of pediatric medical conditions, with the current evidence base drawing from hundreds of studies including both interventional trials and real-world observational data....
`Endocannabinoid System Research: Cannabis for PTSD & SUD`
Clinical Takeaway Trauma-focused treatments remain effective for PTSD even when patients are actively using cannabis, including those with co-occurring substance use disorders. Clinicians should not withhold or delay evidence-based PTSD care based...
`Endocannabinoid System Research: Cannabis for PTSD + SUD`
Clinical Takeaway Trauma-focused therapies remain effective for PTSD even when patients are actively using cannabis, including those with co-occurring substance use disorders. Clinicians should not withhold or delay evidence-based PTSD treatment due...
Adolescent Cannabis Use and Psychotic Disorder Risk
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These findings...
`Endocannabinoid System Research: Cannabis, PTSD & SUD Care`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and cannabis use does not appear to undermine treatment outcomes compared to...